Under an obese state in breast cancer, leptin interacts with molecular effectors such has estrogen, insulin, IGF-1 and inflammatory cytokines, which impacts various stages of breast cancer from initiation to metastatic progression [141]. The gene discussed is INS; the disease is breast carcinoma.